+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ibuprofen"

From
From
From
Non-Opioid Pain Patch Global Market Report 2024 - Product Thumbnail Image

Non-Opioid Pain Patch Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024 - Product Thumbnail Image

Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Pain Management Drugs Global Market Report 2024 - Product Thumbnail Image

Pain Management Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Sinusitis - Pipeline Insight, 2024 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Chronic Lower Back Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Lower Back Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Acute Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator

The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps. The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more